Sponsor Pipeline

Jacobio Pharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
9
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
6
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07684157 A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis Rheumatoid Arthritis (RA) Not Yet Recruiting
Phase 1/2
NCT04686682 A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NSCLC Recruiting
NCT05490472 JAB-2485 Activity in Adult Patients With Advanced Solid Tumors Solid Tumors Recruiting
NCT06973564 JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration Advanced Solid Tumors Recruiting
NCT06959615 A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS… Advanced Solid Tumor Recruiting
NCT06386146 JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation Solid Tumors Recruiting
NCT07640295 Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC… Metastatic Pancreatic Ductal Adenocarcinoma Not Yet Recruiting
Disease Areas
Get alerts when Jacobio Pharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free